Pam Belluck's profile photo

Pam Belluck

Health and Science Reporter at The New York Times

New York Times writer covering health & science. Author of "Island Practice," a book about a quirky island doctor. Jazz flutist. Lapsed Ultimate Frisbee player.

Featured in: Favicon nytimes.com Favicon uol.com.br (+1) Favicon msn.com Favicon globo.com Favicon estadao.com.br Favicon terra.com.br Favicon indiatimes.com (+1) Favicon independent.co.uk Favicon yahoo.com (+6) Favicon clarin.com

Articles

  • 1 day ago | nytimes.com | Pam Belluck

    The states consider it a move to force the F.D.A. to review and acknowledge extensive research showing the pill's safety. In a strategy aimed at countering efforts to further restrict the abortion pill mifepristone, attorneys general of four states that support abortion rights on Thursday asked the Food and Drug Administration to do the opposite and lift the most stringent remaining restrictions on the pill.

  • 1 week ago | nytimes.com | Rachel Abrams |Pam Belluck |Alex Stern |Will Reid |Diana Nguyen |Mary Wilson | +6 more

    Fact-checking by Susan Lee. The Daily is made by Rachel Quester, Lynsea Garrison, Clare Toeniskoetter, Paige Cowett, Michael Simon Johnson, Brad Fisher, Chris Wood, Jessica Cheung, Stella Tan, Alexandra Leigh Young, Lisa Chow, Eric Krupke, Marc Georges, M.J. Davis Lin, Dan Powell, Sydney Harper, Michael Benoist, Liz O.

  • 2 weeks ago | nytimes.com | Pam Belluck

    Se trata de un paso hacia el objetivo de algún día poder diagnosticar la enfermedad con el pinchazo de un dedo. Una prueba de sangre que puede ayudar a diagnosticar la enfermedad de Alzheimer ha recibido la autorización de la Administración de Alimentos y Medicamentos (FDA por su sigla en inglés). Se trata de un paso hacia el objetivo de científicos y médicos de poder diagnosticar algún día una enfermedad confusa con el pinchazo de un dedo. Pero aún queda mucho camino por recorrer.

  • 2 weeks ago | myheraldreview.com | Pam Belluck

    A blood test that can help diagnose Alzheimer’s disease has received clearance from the Food and Drug Administration. This is a step toward a goal of scientists and doctors to one day be able to diagnose a confounding illness with the prick of a finger. But there is still a long way to go. Here is what to know:kAmkDEC@?8m(92E :D E96 E6DE[ 2?5 9@H D9@F=5 :E 36 FD65nk^DEC@?8mk^AmkAm%96 E6DE[ >2?F724EFC65 3J uF;:C63:@ s:28?@DE:4D[ :D :?E6?565 E@ 36 FD65 @?=J 3J DA64:2=:DED :?

  • 2 weeks ago | nytimes.com | Pam Belluck

    The test may make it easier to identify whether people with memory and thinking problems have Alzheimer's or not. A blood test that can help diagnose Alzheimer's disease has received clearance from the Food and Drug Administration. This is a step toward a goal of scientists and doctors to one day be able to diagnose a confounding illness with the prick of a finger. But there is still a long way to go.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Coverage map

X (formerly Twitter)

Followers
11K
Tweets
7K
DMs Open
Yes
Pam Belluck
Pam Belluck @PamBelluck
5 May 25

NEW: Trump administration asks court to dismiss abortion pill case https://t.co/49VdnIwqmI

Pam Belluck
Pam Belluck @PamBelluck
2 Apr 25

NEW: Getting the shingles vaccine has an additional upside: research shows it can reduce the risk of dementia. https://t.co/ZevI9bq4FD

Pam Belluck
Pam Belluck @PamBelluck
27 Mar 25

NEW: In a first, a NY county clerk blocks a Texas court filing against a doctor for providing abortion pills. The move sets up a legal showdown over shield laws and the battle between states that ban abortion and states that support abortion rights. https://t.co/w5S5hoKkG8